Zanran Article preview


Title: United States top 40 anti-infective agents by sales, sales change, number of prescriptions, change in number of prescriptions, advertising expenditures and change in advertising expenditures in dollars and percentages for 2010
Source: Medical Marketing & Media
Date: Aug 2011
Price: $20.00
Categories:
  • Pharmaceutical preparations
  • Pharmaceutical
  • Pharmaceuticals NEC
Buy now with data
Cancel and return to results

Start of full article - but without data

Table

TOP XX INFECTOUS DISEASE PRODUCTS, 2010

Categoty leaders, ranked by 2010 US sales, and their media spend

Rank  Product          Manufacturer     US sales dollars       %
                                          (millions) *    change
                                                             vs.
                                                           prior
                                                              XX
                                                            mos.
X     Atripla          BMS/Gilead               $X,XXX.X   XX.X%
X     Levaquin         Johnson &                $X,XXX.X   -X.X%
                       Johnson
X     Truvada          Gilead                   $X,XXX.X   XX.X%
X     Azithromycin     Generic                  $X,XXX.X   -X.X%
X     Zosyn            Pfizer                     $XXX.X   -X.X%
X     Reyataz          Bristol-Myers    $XXX.X([dagger])    X.X%
                       Squibb
X     Solodyn          Medicis                    $XXX.X   XX.X%
X     Amoxicillin      Generic                    $XXX.X   -X.X%
      tr./clavulanate
X     Zyvox            Pfizer                     $XXX.X   -X.X%
XX    Prevnar XX       Pfizer                     $XXX.X     N/A
XX    Ciprofloxacin    Generic                    $XXX.X    X.X%
      HCI
XX    Isentress        Merck                      $XXX.X   XX.X%
XX    Pegasys          Roche                      $XXX.X    X.X%
XX    Norvir           Abbott                     $XXX.X   XX.X%
XX    Cubicin          Cubist                     $XXX.X    X.X%
XX    Prezista         Johnson &                  $XXX.X   XX.X%
                       Johnson
XX    Epzicom          ViiV Healthcare            $XXX.X   XX.X%
XX    Kaletra          Abbott                     $XXX.X  -XX.X%
XX    Cefdinir         Generic                    $XXX.X   -X.X%
XX    Avelox           Bayer                      $XXX.X  -XX.X%
                       HealthCare
XX    Doryx            Warner Chilcott            $XXX.X   XX.X%
XX    Viread           Gilead                     $XXX.X   XX.X%
XX    Amoxicillin      Generic                    $XXX.X    X.X%
XX    Combivir         ViiV Healthcare            $XXX.X   -X.X%
XX    Vancomycin HCI   Generic                    $XXX.X    X.X%
XX    Vancocin HCI     ViroPharma                 $XXX.X   XX.X%
XX    Cephalexin       Generic                    $XXX.X    X.X%
XX    Engerix-B        GlaxoSmithKline            $XXX.X    X.X%
XX    Fluvirin         Novartis                   $XXX.X   XX.X%
XX    Oracea           Galderma                   $XXX.X   XX.X%
XX    Tobi             Novartis                   $XXX.X    X.X%
XX    Minocycline HCI  Generic                    $XXX.X   -X.X%
XX    Co-trimoxazole   Generic                    $XXX.X    X.X%
XX    Invanz           Merck                      $XXX.X   XX.X%
XX    Sustiva          Bristol-Myers              $XXX.X  -XX.X%
                       Squibb
XX    Clindamycin HCI  Generic                    $XXX.X    X.X%
XX    Pneumovax XX     Merck                      $XXX.X   XX.X%
XX    Primaxin         Merck                      $XXX.X   -X.X%
XX    Merrem           AstraZeneca                $XXX.X  -XX.X%
XX    Tygacil          Pfizer                     $XXX.X   -X.X%

...

About Feedback PDF wizardry Twitter LinkedIn facebook Google+